SCHEMBL3077528

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3083426	0.93	AR (0.41)	ARRECQLSMN1; SMN2POLBTDP1
	SCHEMBL3077471	0.91	AR (0.41)	ARRECQLSMN1; SMN2
	SCHEMBL3076198	0.91	AR (0.43)	ARPOLBPTGDR2
	SCHEMBL3070014	0.91	AR (0.45)	ARPTGDR2
	SCHEMBL3076104	0.90	AR (0.42)	ARSMN1; SMN2
	SCHEMBL3073282	0.90	AR (0.44)	ARRECQLSMN1; SMN2
	SCHEMBL3069866	0.89	MEN1 (0.42)	ARSMN1; SMN2POLB
	SCHEMBL3069970	0.89	AR (0.51)	ARRECQLSMN1; SMN2POLBTDP1
	SCHEMBL3088555	0.89	AR (0.59)	ARPTGDR2
	SCHEMBL3081391	0.89	AR (0.48)	ARPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.